CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...

mRNA injections could reduce aggressive ovarian tumors by rescuing an often mutated gene in high-grade serous ovarian patients, according to a preclinical study. The most common form of ovarian cancer ...

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...

An mRNA therapy could treat the potentially deadly pregnancy disorder preeclampsia, which currently has no cure, a new study in rodents finds. There are currently no drugs that slow the progression of ...

The expansive new study on COVID-19 vaccines during the first trimester of pregnancy comes amid the Trump administration’s ...

PHILADELPHIA—An experimental immunotherapy can temporarily reprogram patients’ immune cells to attack a specific target via only a single injection of messenger RNA (mRNA), similar to the mRNA-based ...

News of marketing approval for China’s first mRNA vaccine falls flat with investors, who worry the drug is being rushed to market before Phase 3 trials are complete As the pandemic abates, the market ...

France enacted a controversial new law in February that critics say could be used against anyone oppos ing injections with mRNA vaccines or other treatments recommended by the state and based upon ...

An experimental immunotherapy can temporarily reprogram patients' immune cells to attack a specific target via only a single injection of messenger RNA (mRNA), similar to the mRNA-based COVID-19 ...